Trial Profile
A Study Evaluating Effectiveness Of Tolvaptan In Preventing The New Onset Of Atrial Fibrillation After Cardiac Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 31 Dec 2016 New trial record
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association.